Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death

PHASE4RecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

November 29, 2016

Primary Completion Date

December 31, 2030

Study Completion Date

June 30, 2031

Conditions
Angina Pectoris, VariantSudden Cardiac Death
Interventions
DEVICE

Implantable Cardioverter Defibrillator

Implantable Cardioverter Defibrillator and Optimal Medical Therapy

DRUG

Optimal Medical Therapy

Trial Locations (25)

Unknown

RECRUITING

Soon Chun Hyang University Hospital Bucheon, Bucheon-si

RECRUITING

Busan National University Yangsan Hospital, Busan

RECRUITING

Busan University Hospital, Busan

RECRUITING

Dong-A Medical Center, Busan

RECRUITING

Soon Chun Hyang University Hospital Cheonan, Cheonan

RECRUITING

Keimyung University Dongsan Medical Center, Daegu

RECRUITING

Chungnam National University Hospital, Daejeon

WITHDRAWN

Gangneung Asan Hospital, Gangneung

RECRUITING

Chonnam National University Hospital, Gwangju

WITHDRAWN

Wonkwang University Hospital, Iksan

RECRUITING

Gachon University Gil Medical Center, Incheon

RECRUITING

Chonbuk National University Hospital, Jeonju

RECRUITING

Chungnam National University Sejong Hospital, Sejong

RECRUITING

Seoul university Bundang hospital, Seongnam

RECRUITING

Asan Medical Center, Seoul

RECRUITING

Ewha Womans University Mokdong Hospital, Seoul

RECRUITING

Kangdong KyungHee University hospital, Seoul

RECRUITING

Korea University Anam Hospital, Seoul

TERMINATED

Korea University Guro Hospital, Seoul

RECRUITING

Seoul National University Boramae Medical Center, Seoul

RECRUITING

Seoul National University Hospital, Seoul

WITHDRAWN

Severance Hospital, Seoul

RECRUITING

The Catholic Univ. of Korea, Seoul St. Mary's Hospital, Seoul

WITHDRAWN

The Catholic University of Korea, Eunpyeong St. Mary's Hospital, Seoul

ACTIVE_NOT_RECRUITING

Ajou University Hospital, Suwon

All Listed Sponsors
collaborator

CardioVascular Research Foundation, Korea

OTHER

lead

Kee-joon Choi

OTHER